about
Gadolinium-based nanoparticles for theranostic MRI-radiosensitization3D Imaging of Nanoparticle Distribution in Biological Tissue by Laser-Induced Breakdown SpectroscopyLaser spectrometry for multi-elemental imaging of biological tissues.Bifunctional polypyridyl-Ru(II) complex grafted onto gadolinium-based nanoparticles for MR-imaging and photodynamic therapy.Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.Laser-induced breakdown spectroscopy: a new approach for nanoparticle's mapping and quantification in organ tissue.Multifunctional material based on ionic transition metal complexes and gold-silica nanoparticles: synthesis and photophysical characterization for application in imaging and therapy.Long-term in vivo clearance of gadolinium-based AGuIX nanoparticles and their biocompatibility after systemic injection.The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy.Ultrasmall Nanoplatforms as Calcium-Responsive Contrast Agents for Magnetic Resonance Imaging.Targeted delivery of a proapoptotic peptide to tumors in vivo.Innovative multimodal DOTA/NODA nanoparticles for MRI and PET imaging for tumor detectionCorrigendum: Laser spectrometry for multi-elemental imaging of biological tissues.Bax-derived membrane-active peptides act as potent and direct inducers of apoptosis in cancer cells.Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I Trial.An MRI-based classification scheme to predict passive access of 5 to 50-nm large nanoparticles to tumors.Application of click-click chemistry to the synthesis of new multivalent RGD conjugates.The High Radiosensitizing Efficiency of a Trace of Gadolinium-Based Nanoparticles in TumorsSafety Evaluation and Imaging Properties of Gadolinium-Based Nanoparticles in nonhuman primates.Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.Optical small animal imaging in the drug discovery process.The multiple roles of amphiregulin in human cancer.Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation TherapyGadolinium nanoparticles and contrast agent as radiation sensitizers.Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging.FRET imaging approaches for in vitro and in vivo characterization of synthetic lipid nanoparticles.Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins.Monte Carlo simulations guided by imaging to predict the in vitro ranking of radiosensitizing nanoparticles.Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles.Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.Drug development in oncology assisted by noninvasive optical imaging.Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model.Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models.Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy.A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications.Effect of particle size on the biodistribution of lipid nanocapsules: comparison between nuclear and fluorescence imaging and counting.How should we plan the future of nanomedicine for cancer diagnosis and therapy?Orotracheal manganese-enhanced MRI (MEMRI): An effective approach for lung tumor detection.Characterization of foreign materials in paraffin-embedded pathological specimens using in situ multi-elemental imaging with laser spectroscopy.MRI-guided clinical 6-MV radiosensitization of glioma using a unique gadolinium-based nanoparticles injection.
P50
Q27027308-38D37967-69A4-4FE9-AA29-56CC1AF8EFB8Q28596080-AC5AA859-7700-4B1D-BE8B-5F4080F3133BQ28654458-586C466E-F7B1-4169-89BF-0351D4B968AFQ30655635-28A59CD3-FC22-40C2-90B9-8EFA5D783309Q33731181-611BB934-143D-45F2-8BAE-D55BF89F41ADQ35194308-A9031E48-B13F-4E18-B095-FE8629B47B0AQ35334021-E16E2610-CF24-4636-B6E0-85686E80A897Q35565059-0AE12F44-B4E3-45B3-936D-8AA566BF67B6Q35676729-E06B3249-956B-4515-8823-93E90DCE08FBQ35693019-E7068F94-C9B5-4714-9C46-97E896B8FC53Q35884337-84280A24-47B6-468F-9BCA-DB9EBAAF78EAQ35986031-B5DE3791-BF12-4AF9-8634-FBA39B7953CFQ35996635-7C8A4718-0EA8-4434-84A6-EDDC1DADDB41Q36191432-1D501273-6453-458B-B704-7784E0F61CE9Q36534202-95558BC0-68D6-410F-8768-8A3008A09198Q36596242-63BC2D32-4D69-420B-9415-CEAAF3195000Q36773033-0B40760F-A4CB-4771-891F-EE1C98E9180BQ37093101-FAC6CFA0-78B6-47B1-8DC1-DDDD9AA12EF1Q37325488-418B6E64-780E-4ED4-A581-0B6AA449BF61Q37383038-9B7941EB-BE36-4860-9D52-E8D31AAC11E5Q37719807-9161D4DE-D7F6-4896-9421-1FE75F0EA73FQ37887106-369D6DA5-ED54-4B37-84D2-F623FB090F38Q38831572-E140EC05-ABE8-4A80-9B67-98E2E11D76B2Q38873201-14880DD4-4A24-40DC-9A4A-4823C24CFD72Q38931279-582A21F4-BDB3-4229-8040-7066D7850BADQ38968298-F63D0B73-E9C5-45EF-A346-EF963B35A7DFQ39104866-C77EFEB1-803B-4145-9C1A-91CECCF7B88DQ39128220-CD9BC1EB-5A7D-4883-AE43-F4D12B6E72C7Q39263680-0FE1DEAE-E62B-4712-A0AB-19E609CB6D67Q39292740-40353646-AEB1-49B6-8B70-AE4CD5EBF66EQ39847415-D29224BA-2624-451B-9C3A-190F01A8D716Q46181883-A6206879-83EF-478F-883D-73CFAB2F3313Q46228126-F014B521-EAB2-41B8-AC75-3F2C3813216FQ46515504-65C62C7B-AFC1-4A04-840C-9A2F5B1B7E06Q46604468-3F43F752-CF42-4BBB-BCBC-CA3C8D8EA747Q47230608-CB42731E-BE8D-449F-BDA3-CF03C63A3B3EQ48042122-9F3321EA-1E12-4E04-B43E-FBE2EC6AAFC7Q48132989-29076E6A-EDC4-4587-9A32-6FAEBF75A7A7Q48283743-505790FC-A9D9-4FF6-8170-69A851149362Q48568336-76F5D488-EB95-4B27-8EDB-19219D9C0AD0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lucie Sancey
@ast
Lucie Sancey
@en
Lucie Sancey
@es
Lucie Sancey
@nl
type
label
Lucie Sancey
@ast
Lucie Sancey
@en
Lucie Sancey
@es
Lucie Sancey
@nl
prefLabel
Lucie Sancey
@ast
Lucie Sancey
@en
Lucie Sancey
@es
Lucie Sancey
@nl
P106
P31
P496
0000-0002-0084-3775